Sign in
  Edit search
Exposure to rifampicin is strongly reduced in patients with …
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.
Article, Chapter
Authors: H.M.J. Nijland
Publication: Clinical Infectious Diseases, Volume:43, Page(s):848
Published: 2006
ISSN: 1058-4838
  Full text availability for this item
View Full Text Source:Clinical Infectious Diseases,Clinical Infectious Diseases,Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Journal:  Clinical Infectious Diseases Source:Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Collection:  Oxford University Press Journals (UKB 2021-2023)
Coverage:
  • 1996~present; volume:22~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item